Ironwood Pharmaceuticals (IRWD) Divestments (2010 - 2019)
Ironwood Pharmaceuticals' (IRWD) quarterly Divestments came in at -$4.2 million in Q1 2019, down 38.6% quarter-over-quarter from -$3.0 million in Q4 2018.
Powered by 
Analysis
Ironwood Pharmaceuticals (IRWD) Divestments (2010 - 2019) Analysis & Trends
Ironwood Pharmaceuticals has disclosed Divestments across 3 years of filings, most recently posting -$4.2 million for Q1 2019.
- In Q1 2019, Divestments changed N/A year-over-year to -$4.2 million; the TTM figure through Dec 2019 stood at -$4.2 million (down 241.57% YoY), while the FY2019 annual figure was -$4.2 million, up 48.94% from the prior year.
- Divestments came in at -$4.2 million for Q1 2019 at Ironwood Pharmaceuticals, down from -$3.0 million in the prior quarter.
- In the past five years, Divestments ranged from a high of -$3.0 million in Q4 2018 to a low of -$4.2 million in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.95 Bn | 195.96 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.35 Bn | 177.17 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.26 Bn | 124.41 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.62 Bn | 74.62 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.19 Bn | 56.00 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.75 Bn | 30.44 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.58 Bn | 30.30 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.42 Bn | 29.42 Bn | 1.16 Mn | - |
| 10 | Ironwood Pharmaceuticals | 658.89 Mn | 579.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | -4.22 Mn |
| Dec 31, 2018 | -3.05 Mn |
| Sep 30, 2018 | -3.47 Mn |
| Dec 31, 2010 | -1,000.00 |
| Sep 30, 2010 | 9.50 Mn |